Overview

A Study of Single Ascending Doses of LEM-S401 in Healthy Participants

Status:
Not yet recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the safety and tolerability of single dose of LEM-S401 in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Lemonex
Lemonex Inc.
Collaborator:
Covance